C1q/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects

XiuYa Zeng1,2, YouYuan Peng3, YanFeng Wang1,2

  • 1Department of Clinical Laboratory, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

Bioengineered
|February 23, 2022
PubMed

Insights

C1q/tumor necrosis factor-related protein-3 (CTRP3) protects against high glucose-induced damage in diabetic retinopathy (DR). Forkhead box O4 (FOXO4) inhibits CTRP3, exacerbating oxidative stress and apoptosis in retinal pericytes.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness in diabetes mellitus patients.
  • C1q/tumor necrosis factor-related protein-3 (CTRP3), a novel adipokine, has roles in metabolism, but its function in DR is unclear.
  • High glucose (HG) conditions impact human retinal pericytes (HRPs), crucial cells in retinal vasculature.

Purpose of the Study:

  • To investigate the effect of CTRP3 on HG-induced HRPs.
  • To elucidate the regulatory mechanism involving CTRP3 in HG-induced HRPs.
  • To assess the role of CTRP3 in the context of diabetic retinopathy pathogenesis.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) and Western blot for CTRP3 and FOXO4 expression analysis.
  • Cell Counting Kit-8 (CCK-8) for proliferation and TUNEL assay for apoptosis assessment.
  • Analysis of oxidative stress biomarkers (MnSOD, CAT, MDA) and verification of FOXO4-CTRP3 interaction using ChIP and luciferase assays.

Main Results:

  • CTRP3 expression was reduced, while FOXO4 expression was elevated in HG-stimulated HRPs.
  • CTRP3 overexpression improved HRP viability, reduced apoptosis, and mitigated oxidative stress.
  • FOXO4 directly binds to the CTRP3 promoter, inhibiting its transcription and modulating the Nrf2/NF-κB signaling pathway.

Conclusions:

  • CTRP3 plays a protective role against HG-induced oxidative damage in HRPs, relevant to DR.
  • FOXO4 negatively regulates CTRP3, contributing to HG-induced cellular damage in DR.
  • CTRP3, via modulation of the Nrf2/NF-κB pathway, offers a potential therapeutic target for DR.

Related Concept Videos